Similar articles

• Lack of relationship of neuroleptic dose and blood serum levels to neuropsychological performance on the LNNB in chronic schizophrenia.

  Puente AE, Tune L. Puente AE, et al. Int J Neurosci. 1996 Oct;87(1-2):107-10. doi: 10.3109/00207459608990759. Int J Neurosci. 1996. PMID: 8913825
• [Use of insulin and neuroleptics in treating schizophrenics].

  Maliarov SA, Shpakovich VIa. Maliarov SA, et al. Vrach Delo. 1988 Sep;(9):96-7. Vrach Delo. 1988. PMID: 2905550 Russian. No abstract available.
• [Discontinuation of neuroleptics in chronic schizophrenics. I. Summary of the literature].

  Woggon B. Woggon B. Int Pharmacopsychiatry. 1979;14(1):34-56. Int Pharmacopsychiatry. 1979. PMID: 39040 Review. German.
• Neuroleptic dosing in chronic schizophrenia: a 10-year follow-up.

  Remington GJ, Prendergast P, Bezchlibnyk-Butler KZ. Remington GJ, et al. Can J Psychiatry. 1997 Feb;42(1):53-7. doi: 10.1177/070674379704200108. Can J Psychiatry. 1997. PMID: 9040924
• Antipsychotic medication: clinical guidelines for maintenance therapy.

  Johnson DA. Johnson DA. J Clin Psychiatry. 1985 May;46(5 Pt 2):6-15. J Clin Psychiatry. 1985. PMID: 2859281 Review.